Lucentis

Lucentis (Ranibizumab) is an intravitreal injection used to treat eye conditions like wet age-related macular degeneration. This medication helps maintain vision by targeting abnormal blood vessel growth.

Lucentis is primarily used for the treatment of wet age-related macular degeneration, a condition that can lead to vision loss. It may also be prescribed for other eye conditions involving abnormal blood vessel growth. Patients often ask, 'What is Lucentis used for?' and the answer involves its role in managing specific retinal disorders.

Common effects of Lucentis may include eye redness, floaters, or increased eye pressure. Some patients might experience temporary vision changes. These effects are generally mild and temporary, but any concerns should be discussed with a healthcare provider.

Lucentis should be handled with care, following the instructions provided by a healthcare professional. It is important to inform your doctor about any existing eye conditions or allergies before starting treatment. Proper storage and handling are crucial to maintain the medication's effectiveness.

Lucentis may interact with other medications, particularly those used to treat eye conditions. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain supplements may also affect the treatment's efficacy.